Project · Software & science

MoodMonitor

Keeping providers and patients in touch through treatment for treatment-resistant depression.

Merged
Where
Ketamine clinics, U.S.
Since
2016
Reach
50+ clinics at merger
With
Noah Heller
Status
Merged into Osmind, September 2020

MoodMonitor is clinical software that keeps providers and patients in touch through treatment for treatment-resistant depression.

I co-founded MoodMonitor in 2016 with Noah Heller. Ketamine was emerging as a breakthrough treatment for depression, but outcomes depend on tracking patients' mood closely between sessions — and only about 11% of patients keep up a paper mood journal. We built MoodMonitor to close that gap: a HIPAA-compliant platform where patients receive a daily check-in by text message, complete clinically verified surveys every other week, and both patient and doctor watch progress chart in real time, together.

By the time we joined Osmind, more than 50 ketamine clinics and their patients nationwide used it — with over 90% of patients keeping up daily monitoring via text message.

The Osmind merger

In 2020, the ketamine and psychedelic therapy landscape evolved rapidly — new technologies, practices, and funders entered the space with great resources. We saw that MoodMonitor needed to change to keep providing the best possible service to our clinics and patients — and we're very excited to announce that change. MoodMonitor joined forces with Osmind.

We strongly believe Osmind is the best choice for ketamine practices and the future of ketamine and psychedelic therapy. They are already used all across the country and Lucia, Jimmy, and the Osmind team are aligned with our mission and care as deeply about patients as we do. We trust them to continue our work together helping patients.

We will no longer be working full-time on the project, but stayed on as advisors at Osmind and are available to talk at any time. Osmind continued to operate MoodMonitor for existing clinics so no patients lost care.

Screens · the mark

MoodMonitor logo — green low-poly brain mark beside the MoodMonitor wordmark

Screens · the product, as seen on CNN

MoodMonitor's Depression Severity Chart on CNN — Sanjay Gupta reporting under the headline “Party drug ketamine found to help those with suicidal thoughts,” August 2018 Depression Severity Chart — severity bands from None to Severe, a red line rising out of Severe in late May, and the date axis MoodMonitor mood chart — a daily 0–10 mood score line over time, with a ketamine-treatment marker MoodMonitor provider dashboard — patient table with mood scores, trend arrows, and depression severity MoodMonitor on a tablet — depression severity chart over PHQ-9 questionnaires, sending a patient report MoodMonitor survey settings — scheduling PHQ-9 and BPI pain surveys before and after treatment

By the numbers

11%of patients keep up a paper mood journal
90%+kept up daily SMS monitoring on MoodMonitor
50+clinics nationwide at merger

Links

Announcement — "MoodMonitor Joins the Osmind Platform" (Osmind blog, Sept 1, 2020)
The CNN segment that used our chart — “Party drug ketamine found to help those with suicidal thoughts” (Sanjay Gupta, Aug 2018) — the MoodMonitor Depression Severity Chart on national TV.
Osmind, carrying it forward — osmind.org
The archived product site — moodmonitor.co (2019)
Original merger blog post (archived) — "Exciting news from MoodMonitor: we are merging with Osmind!"